Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and Active Pharmaceutical Ingredient (APIs). It operates across a wide scope of areas, including Gynecology, Cardiovascular, HIV Antivirals, VMN (Vitamins, Minerals & Nutrients), Pain/Analgesics, Nephrology, Oncology, Anti-Infective, Respiratory, CNS. Its brands include Orofer XT and Pause (Gynecological), Proxym (pain), Tenectase (CNS), Vylda (diabetology), Vitanova (VMN). Its API products include S-Amlodipine, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (Tenecteplase), Vintor (Erythropoietin), TENECTASE (Tenecteplase). It has developed two platforms: Mammalian and Microbial.
Emcure Pharmaceuticals Ltd FAQs
How to Buy Emcure Pharmaceuticals Ltd Share?
To purchase Emcure Pharmaceuticals Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Emcure Pharmaceuticals Ltd (ticker symbol: EMCURE) on the trading platform provided by your broker and purchase the shares.
The stock price of Emcure Pharmaceuticals Ltd as of 10 Jul 2026 is ₹1,778.80
What is the Market Cap of Emcure Pharmaceuticals Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 10 Jul 2026, Emcure Pharmaceuticals Ltd (ticker symbol: EMCURE) has a market capitalisation of approximately ₹3,48,80,00,00,000.00
What is the PE and PB ratio of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd Ltd's price-to-book ratio as of 10 Jul 2026 is 7.6, reflecting the market's valuation compared to its asset value. As of 10 Jul 2026, the trailing twelve months P/E (price-to-earnings) ratio is 36.48, indicating the market values the company at around ₹36.48 for every ₹1 of earnings
What is the 52 Week High and Low of Emcure Pharmaceuticals Ltd Share?
Emcure Pharmaceuticals Ltd Ltd (EMCURE) hit its 52-week high at ₹1,900.62, and its 52-week low at ₹1,246.57.